Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| Nagstatin | IC50 | 1.83 [1] | |
| Nagstatin | Ki | 0.93 [1] | |
| N-[[(1R,2S,3S,5S,7R,8S)-1,2,7-Trihydroxy-5-(hydroxymethyl)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-3-yl]methyl]acetamide | IC50 | 2.39 [1] | |
| N-[[(1R,2S,3S,5S,7R,8S)-1,2,7-Trihydroxy-5-(hydroxymethyl)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-3-yl]methyl]acetamide | Ki | 1.25 [1] | |
| (2S,3S)-3-Hydroxybaikiain | IC50 | 750000.0 [1] | |
MLA | "Quest Database™ Endo-beta-N-acetylglucosaminidase Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 3 Apr. 2026, https://www.aatbio.com/data-sets/endo-beta-n-acetylglucosaminidase-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2026, April 3). Quest Database™ Endo-beta-N-acetylglucosaminidase Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/endo-beta-n-acetylglucosaminidase-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |